These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


80 related items for PubMed ID: 3863256

  • 1. [Autogenic anti-idiotypic suppression of autoimmune reactions--a new approach to immunotherapy of experimental leukemia].
    Ter-Grigorov VS, Krupnik VE, Etkin AF, Pivnik AV, Moskovkina OIa.
    Ter Arkh; 1985; 57(7):108-12. PubMed ID: 3863256
    [Abstract] [Full Text] [Related]

  • 2. Autoimmunity and counter-autoimmunity in the mechanisms of retrovirus-induced leukemogenesis.
    Ter-Grigorov V.
    Leukemia; 1992; 6 Suppl 3():171S-173S. PubMed ID: 1318469
    [Abstract] [Full Text] [Related]

  • 3. Genetic control of antinuclear antibodies in mice infected with Rauscher leukemia virus.
    Varet B, Cannat A, Gisselbrecht S.
    Cancer Res; 1977 Apr; 37(4):1115-8. PubMed ID: 300277
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.
    Sanfilippo F, Genovesi EV, Collins JJ.
    J Natl Cancer Inst; 1981 Sep; 67(3):703-17. PubMed ID: 6456369
    [Abstract] [Full Text] [Related]

  • 5. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA, Ciavarra R, Riblet R, Forman J.
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [Abstract] [Full Text] [Related]

  • 6. Modulation of fetal antigen(s) in mouse leukemia cells.
    Ortaldo JR, Ting CC, Herberman RB.
    Cancer Res; 1974 Jun; 34(6):1366-71. PubMed ID: 4545252
    [No Abstract] [Full Text] [Related]

  • 7. [Humoral autoimmune reactions directed against autoantigens of the H-2 histocompatibility system in mice with developing Rauscher leukemia].
    Ter-Griggorov VS, Moskovkina OIa, Krupnik VE, Graf IA, Pivnik AV.
    Eksp Onkol; 1988 Jun; 10(6):21-5. PubMed ID: 2468468
    [Abstract] [Full Text] [Related]

  • 8. [Properties and identification of the clonogenic cells of self-maintaining strains of Rauscher's erythroleukemia].
    Mechetner EB, Iavleva ES, Rozinova EN, Chizhevskaia MA, Irlin IS.
    Probl Gematol Pereliv Krovi; 1979 Sep; 24(9):51-7. PubMed ID: 290980
    [No Abstract] [Full Text] [Related]

  • 9. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A, Ito Y.
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A, Ito Y.
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract] [Full Text] [Related]

  • 11. Accessory cells in the in vitro generation of type C viruses specific T killer lymphocytes. I. Role of macrophages in primary anti-FMR reaction.
    Gomard E, Wybier-Franqui J, Levy JP.
    J Immunol; 1981 Mar; 126(3):891-6. PubMed ID: 6257785
    [Abstract] [Full Text] [Related]

  • 12. [Mechanism of the modifying effect of neuraminidase of the influenza virus on the development of Rauscher leukemia].
    Novichenko NL, Struk VI.
    Eksp Onkol; 1984 Mar; 6(3):29-32. PubMed ID: 6499739
    [Abstract] [Full Text] [Related]

  • 13. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
    Levite M, Zinger H, Mozes E, Reisner Y.
    Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
    [Abstract] [Full Text] [Related]

  • 14. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR.
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [Abstract] [Full Text] [Related]

  • 15. Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
    Cohen P, Vourka-Karussis U, Weiss L, Slavin S.
    J Immunol; 1993 Nov 01; 151(9):4803-10. PubMed ID: 8409438
    [Abstract] [Full Text] [Related]

  • 16. Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis.
    Erez-Alon N, Herkel J, Wolkowicz R, Ruiz PJ, Waisman A, Rotter V, Cohen IR.
    Cancer Res; 1998 Dec 01; 58(23):5447-52. PubMed ID: 9850078
    [Abstract] [Full Text] [Related]

  • 17. Recognition of a leukemia-related antigen by an antiidiotypic antiserum to an anti-gp70 monoclonal antibody.
    Ardman B, Khiroya RH, Schwartz RS.
    J Exp Med; 1985 Apr 01; 161(4):669-86. PubMed ID: 3856626
    [Abstract] [Full Text] [Related]

  • 18. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M, Ria F, Parrella P, Signori E, Serra A, Ciafrè SA, Vespignani I, Lazzari M, Farace MG, Saglio G, Fazio VM.
    Cancer Res; 2001 Feb 15; 61(4):1555-62. PubMed ID: 11245465
    [Abstract] [Full Text] [Related]

  • 19. Effect of passively administered isologous anti-idiotypes directed against anti-carrier (ovalbumin) antibodies on the anti-hapten IgE and IgG antibody responses in BALB/c mice.
    Blaser K, Nakagawa T, De Weck AL.
    Immunology; 1983 Mar 15; 48(3):423-31. PubMed ID: 6600704
    [Abstract] [Full Text] [Related]

  • 20. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
    Avidan N, Tumas-Brundage KM, Sieck TG, Prystowsky MB, Blank KJ.
    Virology; 1995 Aug 20; 211(2):507-15. PubMed ID: 7645254
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.